Offstream
news

---

Changes

1. The Indonesian Drug and Food Control Agency issues an emergency use authorization of Sinovac Coronavac vaccine for children aged 6 to 11 years old.
   2021-11-02 03:06:17 (First version)
2. The Indonesian Drug and Food Control Agency issues an emergency use authorization for the Sinovac CoronaVac vaccine for children between the ages of 6 and 11 years.
   (Current version)

---

Related

The Indonesian Drug and Food Control Agency issues an emergency use authorization for the three dose Zifivax ZF2001 vaccine.
2021-10-7

Brazilian federal health regulator Anvisa suspends the use of over 12 million doses of the Sinovac CoronaVac vaccine that were produced in an unauthorized plant.
2021-09-4

Cambodia begins a COVID-19 vaccination rollout for teenagers between the ages of 12 and 17 years using the Sinovac CoronaVac vaccine. Prime Minister Hun Sen's grandchildren are among the first to receive the vaccine.
2021-08-1

President Joko Widodo announces that the Indonesian Food and Drug Authority approves the emergency use of the Sinovac CoronaVac vaccine for children aged 12 to 17 years old.
2021-06-28

The World Health Organization issues an emergency use authorization for Sinovac's CoronaVac vaccine, becoming the second Chinese-made vaccine to be approved on an emergency basis after BBIBP-CorV and thereby making it eligible for use as part of the COVAX initiative.
2021-06-1

Albania receives their first shipment of 192,000 doses of the Sinovac CoronaVac vaccine.
2021-03-25

Malaysia grants conditional approval for the use of the Oxford-AstraZeneca and Sinovac CoronaVac vaccines.
2021-03-2

Chile approves the CoronaVac vaccine developed by Sinovac for emergency use in the country.
2021-01-20

Indonesia receives their second shipment of 1.8 million doses of CoronaVac from Sinovac.
2020-12-31

Indonesia aims to start administering COVID-19 vaccines early next month, according to the Coordinating Ministry for Maritime and Investment Affairs. Sinopharm and G42 Healthcare will supply five million doses starting next month, CanSino Biologics will supply 100,000 doses that same time, and Sinovac will supply three million doses of CoronaVac by December. All three vaccines are currently in Phase III trials in various countries.
2020-10-12